Trial Condition(s):

Rosacea

A Study of Patient Concerns and Treatment Satisfaction in Patients Being Treated with Finacea Foam for Rosacea

Bayer Identifier:

19638

ClinicalTrials.gov Identifier:

NCT03193372

EudraCT Number:

Not Available

Study Completed

Trial Purpose

To survey rosacea patients about their concerns, treatment satisfaction, and quality of life associated with their Finacea Foam treatment

Inclusion Criteria
- At least 18 years of age
- Diagnosis of rosacea by a medical professional
- Currently using Finacea Foam as topical monotherapy for rosacea
- Willing and able to provide voluntary, informed consent to participate in this study
Exclusion Criteria
- Use of any other topical treatment for rosacea at the time of enrollment

Trial Summary

Enrollment Goal
2200
Trial Dates
black-arrow
Phase
4
Could I receive a placebo?
No
Products
Finacea® (azelaic acid) Foam, 15% (Azelaic Acid, BAY39-6251)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Xcenda, LLC

Palm Harbor, United States, 34685

Status
Completed
 

Trial Design